Back to Nuveen, LLC Nuveen, LLC

IKTIKT
5 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in INHIBIKASE THERAPEUTICS INC

Nuveen, LLC holds 425,492 shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $863,749 as of 2026-Q2. The position was decreased (-9.9% shares). IKT represents 0.0% of Nuveen, LLC's portfolio.

Current Value

$863,749

Current Shares

425,492

Total Value Change

+$710,364

Total Shares Change

+346,833

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
425,492
-9.9%
$863,7490.0%$2.03
0
2026-Q1
Increased
472,399
+500.6%
$793,6300.0%$1.91
40
2025-Q4
Unchanged
78,659
0.0%
$161,2510.0%$1.97
0
2025-Q3
Unchanged
78,659
0.0%
$127,4280.0%$1.53
0
2025-Q2
New
78,659
-
$153,3850.0%$1.62
34

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used